100 related articles for article (PubMed ID: 27006369)
21. Role of apoptosis in basal cell and squamous cell carcinoma formation.
Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
[TBL] [Abstract][Full Text] [Related]
22. Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.
Bal E; Park HS; Belaid-Choucair Z; Kayserili H; Naville M; Madrange M; Chiticariu E; Hadj-Rabia S; Cagnard N; Kuonen F; Bachmann D; Huber M; Le Gall C; Côté F; Hanein S; Rosti RÖ; Aslanger AD; Waisfisz Q; Bodemer C; Hermine O; Morice-Picard F; Labeille B; Caux F; Mazereeuw-Hautier J; Philip N; Levy N; Taieb A; Avril MF; Headon DJ; Gyapay G; Magnaldo T; Fraitag S; Crollius HR; Vabres P; Hohl D; Munnich A; Smahi A
Nat Med; 2017 Oct; 23(10):1226-1233. PubMed ID: 28869610
[TBL] [Abstract][Full Text] [Related]
23. Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
Tilley C; Deep G; Agarwal R
Mol Carcinog; 2015 Sep; 54(9):688-97. PubMed ID: 26053157
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA expression in basal cell carcinoma.
Sand M; Bechara FG; Sand D; Gambichler T; Hahn SA; Bromba M; Stockfleth E; Hessam S
Epigenomics; 2016 May; 8(5):619-32. PubMed ID: 27097056
[TBL] [Abstract][Full Text] [Related]
25. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
26. Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma.
Lupu M; Caruntu C; Ghita MA; Voiculescu V; Voiculescu S; Rosca AE; Caruntu A; Moraru L; Popa IM; Calenic B; Greabu M; Costea DE
Dis Markers; 2016; 2016():9831237. PubMed ID: 27578920
[TBL] [Abstract][Full Text] [Related]
27. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
28. An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes.
Lesiak A; Norval M; Wodz-Naskiewicz K; Pawliczak R; Rogowski-Tylman M; Sysa-Jedrzejowska A; Sobjanek M; Wlodarkiewicz A; Narbutt J
Exp Dermatol; 2011 Oct; 20(10):800-4. PubMed ID: 21732987
[TBL] [Abstract][Full Text] [Related]
29. Aneuploidy of sex chromosomes in basal cell carcinoma: its clonality and involvement in the development of carcinogenesis.
Koyama N; Nishihira J; Nakabayashi H; Nishi S; Hoshi N; Fujimoto S; Shimizu M; Yoshiki T; Sugihara T
Int J Oncol; 2000 Jan; 16(1):15-23. PubMed ID: 10601543
[TBL] [Abstract][Full Text] [Related]
30. Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma.
DO Carmo NG; Sakamoto LH; Pogue R; DO Couto Mascarenhas C; Passos SK; Felipe MS; DE Andrade RV
Anticancer Res; 2016 Sep; 36(9):4545-51. PubMed ID: 27630294
[TBL] [Abstract][Full Text] [Related]
31. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
32. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
33. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
34. Insight into the pathogenesis of sporadic basal cell carcinoma.
Holíková Z; Massi D; Lotti T; Hercogová J
Int J Dermatol; 2004 Dec; 43(12):865-9. PubMed ID: 15569004
[TBL] [Abstract][Full Text] [Related]
35. Human 8-oxoguanine-DNA glycosylase-1 is downregulated in human basal cell carcinoma.
Huang XX; Scolyer RA; Abubakar A; Halliday GM
Mol Genet Metab; 2012 May; 106(1):127-30. PubMed ID: 22436579
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
[No Abstract] [Full Text] [Related]
37. Xeroderma pigmentosum complementation group C protein (XPC) expression in basal cell carcinoma.
Yang LC; Hsiao YP; Lu CT; Huang CH; Chao WR; Lin YT; Su HA; Chang SL; Chung JG
In Vivo; 2015; 29(1):35-8. PubMed ID: 25600527
[TBL] [Abstract][Full Text] [Related]
38. Hypothesis: overexpression or overactivation of PAR-2 might be involved in the evolution of basal cell carcinoma.
Namazi MR
Dermatol Online J; 2003 Dec; 9(5):32. PubMed ID: 14996405
[No Abstract] [Full Text] [Related]
39. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.
Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA
Genes Dev; 2005 Jan; 19(2):214-23. PubMed ID: 15625189
[TBL] [Abstract][Full Text] [Related]
40. Environment, phenotype and genetics: risk factors associated with BCC of the skin.
Hoban PR; Ramachandran S; Strange RC
Expert Rev Anticancer Ther; 2002 Oct; 2(5):570-9. PubMed ID: 12382525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
